| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996720 | Practical Radiation Oncology | 2015 | 9 Pages |
Abstract
The delivery of higher-dose RT but not concurrent chemotherapy was associated with a significant improvement of OS. This population-based study supports higher-dose palliative regimens and motivates prospective study of escalation beyond a biologically effective dose of 35 Gy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Matthew MD, Renuka MD, Usama MD, Chad G. MD, David J. MD, MPH,